• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国 Citrin 缺乏症患者的饮食管理、临床状况和结局。

Dietary Management, Clinical Status and Outcome of Patients with Citrin Deficiency in the UK.

机构信息

Birmingham Women's and Children's Hospital, Birmingham B4 6NH, UK.

Great Ormond Street Hospital for children, NHS Foundation Trust, London WC1N 3JH, UK.

出版信息

Nutrients. 2020 Oct 29;12(11):3313. doi: 10.3390/nu12113313.

DOI:10.3390/nu12113313
PMID:33137944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7693899/
Abstract

BACKGROUND

Little is known about the optimal dietary treatment for citrin deficiency. Our aim is to describe the management of UK citrin deficiency patients.

METHODS

A longitudinal retrospective review was performed. Data were collected from medical records on presenting signs and symptoms, dietary management and clinical outcome.

RESULTS

data were collected on 32 patients from 21 families. 50% were females (16/32). Median age at diagnosis was 4 y (5 days-35 y) with 12 patients diagnosed in the neonatal period with neonatal intrahepatic cholestasis (NICCD), eight later in childhood (FTTDCD) and 12 by family screening based on index cases from five families. No patient had adult-onset type II citrullinemia. The patient age at the time of data collection was a median of 11 y (1-44 y). 91% (29/32) of patients had normal physical and neurological development, 47% (15/32) experienced recurrent unexplained abdominal pain and 9% (3/32) episodes of hypoglycaemia. Siblings had different phenotypes (5 families had > 1 affected patient). Most patients preferred high protein foods, limiting sugar-containing foods. Only 41% (13/32) were prescribed a low CHO, high protein, high fat diet (restriction varied) and two used medium chain triglyceride (MCT) supplements. No patient was prescribed drug therapy. Twenty-five per cent (8/32) of patients were underweight and 41% (13/32) had height <-1 z-scores.

CONCLUSIONS

patients presented with various phenotypes, symptoms and suboptimal growth. Symptoms and biochemical markers improved with age, but height remained low in some. More research is necessary to assess the effectiveness of dietary approaches in improving clinical outcomes and symptoms in citrin deficiency.

摘要

背景

关于 citrin 缺乏症的最佳饮食治疗方法知之甚少。我们的目的是描述英国 citrin 缺乏症患者的治疗方法。

方法

进行了一项纵向回顾性研究。从病历中收集了发病时的体征和症状、饮食管理和临床结果的数据。

结果

从 21 个家庭的 32 名患者中收集了数据。其中 50%(16/32)为女性。诊断时的中位年龄为 4 岁(5 天至 35 岁),其中 12 例在新生儿期诊断为新生儿肝内胆汁淤积症(NICCD),8 例在儿童期后期(FTTDCD),12 例通过来自五个家庭的指数病例进行家族筛查诊断。没有患者患有成年型 II 型瓜氨酸血症。数据收集时的患者年龄中位数为 11 岁(1-44 岁)。91%(29/32)的患者有正常的体格和神经发育,47%(15/32)有反复发作的不明原因腹痛,9%(3/32)有低血糖发作。兄弟姐妹有不同的表型(5 个家庭有>1 个受影响的患者)。大多数患者喜欢高蛋白食物,限制含糖食物。只有 41%(13/32)被开了低碳水化合物、高蛋白、高脂肪饮食(限制不同),2 人使用中链甘油三酯(MCT)补充剂。没有患者接受药物治疗。25%(8/32)的患者体重不足,41%(13/32)的患者身高<-1 z 分数。

结论

患者表现出各种不同的表型、症状和生长不良。随着年龄的增长,症状和生化标志物有所改善,但一些患者的身高仍然较低。需要进一步研究以评估饮食方法在改善 citrin 缺乏症患者的临床结局和症状方面的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/66202a5176a0/nutrients-12-03313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/a74e847f032d/nutrients-12-03313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/3e155dc943e6/nutrients-12-03313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/66202a5176a0/nutrients-12-03313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/a74e847f032d/nutrients-12-03313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/3e155dc943e6/nutrients-12-03313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/7693899/66202a5176a0/nutrients-12-03313-g003.jpg

相似文献

1
Dietary Management, Clinical Status and Outcome of Patients with Citrin Deficiency in the UK.英国 Citrin 缺乏症患者的饮食管理、临床状况和结局。
Nutrients. 2020 Oct 29;12(11):3313. doi: 10.3390/nu12113313.
2
Citrin Deficiency柠檬酸转运蛋白缺乏症
3
Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.目前针对尼曼匹克 C 型疾病(NICCD)和适应/代偿期 citrin 缺乏症的治疗:预防 CTLN2 的策略。
Mol Genet Metab. 2019 Jul;127(3):175-183. doi: 10.1016/j.ymgme.2019.06.004. Epub 2019 Jun 15.
4
Metabolic basis and treatment of citrin deficiency.柠檬酸合成酶缺乏症的代谢基础与治疗。
J Inherit Metab Dis. 2021 Jan;44(1):110-117. doi: 10.1002/jimd.12294. Epub 2020 Aug 26.
5
Analysis of daily energy, protein, fat, and carbohydrate intake in citrin-deficient patients: Towards prevention of adult-onset type II citrullinemia.分析 Citrin 缺乏症患者的每日能量、蛋白质、脂肪和碳水化合物摄入量:预防成年型 II 型瓜氨酸血症。
Mol Genet Metab. 2021 May;133(1):63-70. doi: 10.1016/j.ymgme.2021.03.004. Epub 2021 Mar 10.
6
Growth impairment in individuals with citrin deficiency.患有 citrin 缺乏症个体的生长障碍。
J Inherit Metab Dis. 2019 May;42(3):501-508. doi: 10.1002/jimd.12051. Epub 2019 Feb 4.
7
Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.在低碳水化合物配方下补充中链甘油三酯是成人型II型瓜氨酸血症的一种有前景的治疗方法。
Mol Genet Metab Rep. 2014 Jan 14;1:42-50. doi: 10.1016/j.ymgmr.2013.12.002. eCollection 2014.
8
Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.补充剂对人 citrin 缺乏症 citrin/线粒体甘油-3-磷酸脱氢酶双敲除小鼠模型的食物摄入、体重和肝代谢物的影响。
Mol Genet Metab. 2012 Nov;107(3):322-9. doi: 10.1016/j.ymgme.2012.07.021. Epub 2012 Aug 2.
9
Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.中链甘油三酯补充疗法与低碳水化合物配方联合应用,可以为成年发病型 II 型瓜氨酸血症患者的肝细胞提供能量并增强氨解毒。
J Inherit Metab Dis. 2018 Sep;41(5):777-784. doi: 10.1007/s10545-018-0176-1. Epub 2018 Apr 12.
10
Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD).线粒体天冬氨酸谷氨酸载体(citrin)缺乏是成人发作性II型瓜氨酸血症(CTLN2)和特发性新生儿肝炎(NICCD)的病因。
J Hum Genet. 2002;47(7):333-41. doi: 10.1007/s100380200046.

引用本文的文献

1
Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical features, genetic characteristics, and treatment outcomes.瓜氨酸血症Ⅱ型所致新生儿肝内胆汁淤积症:临床特征、遗传学特点及治疗转归
BMC Gastroenterol. 2025 Jul 15;25(1):519. doi: 10.1186/s12876-025-04008-5.
2
Single Amino Acid Supplementation in Inherited Metabolic Disorders: An Evidence-Based Review of Interventions.遗传性代谢疾病中的单一氨基酸补充:基于证据的干预措施综述。
Genes (Basel). 2025 Apr 27;16(5):502. doi: 10.3390/genes16050502.
3
Deciphering the Mutational Background in Citrin Deficiency Through a Nationwide Study in Japan and Literature Review.

本文引用的文献

1
Metabolic basis and treatment of citrin deficiency.柠檬酸合成酶缺乏症的代谢基础与治疗。
J Inherit Metab Dis. 2021 Jan;44(1):110-117. doi: 10.1002/jimd.12294. Epub 2020 Aug 26.
2
Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis.经 DNA 分析确诊后,采用低碳水化合物饮食和 L-精氨酸治疗成年发病型 II 型瓜氨酸血症获得成功。
Clin J Gastroenterol. 2020 Oct;13(5):823-833. doi: 10.1007/s12328-019-01083-6. Epub 2020 Jan 2.
3
Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.
通过日本全国性研究及文献回顾解读瓜氨酸血症的突变背景
Hum Mutat. 2025 Apr 22;2025:9326326. doi: 10.1155/humu/9326326. eCollection 2025.
4
Current Understanding of Pathogenic Mechanisms and Disease Models of Citrin Deficiency.瓜氨酸缺乏症的致病机制及疾病模型的当前认识
J Inherit Metab Dis. 2025 Mar;48(2):e70021. doi: 10.1002/jimd.70021.
5
The therapeutic landscape of citrin deficiency.瓜氨酸血症的治疗景观。
J Inherit Metab Dis. 2024 Nov;47(6):1157-1174. doi: 10.1002/jimd.12768. Epub 2024 Jul 17.
6
Citrin deficiency-The East-side story.Citrin 缺乏症——东边的故事。
J Inherit Metab Dis. 2024 Nov;47(6):1129-1133. doi: 10.1002/jimd.12772. Epub 2024 Jul 12.
7
Clinical landscape of citrin deficiency: A global perspective on a multifaceted condition. citrin 缺乏症的临床概况:一种多方面疾病的全球视角。
J Inherit Metab Dis. 2024 Nov;47(6):1144-1156. doi: 10.1002/jimd.12722. Epub 2024 Mar 19.
8
Citrin Deficiency: Clinical and Nutritional Features.Citrin 缺乏症:临床和营养特征。
Nutrients. 2023 May 12;15(10):2284. doi: 10.3390/nu15102284.
9
Challenges in pediatric inherited/metabolic liver disease: Focus on the disease spectrum, diagnosis and management of relatively common disorders.儿科遗传性/代谢性肝病的挑战:重点关注相对常见疾病的疾病谱、诊断和治疗。
World J Gastroenterol. 2023 Apr 14;29(14):2114-2126. doi: 10.3748/wjg.v29.i14.2114.
10
Obstacles to home-based dietary management for caregivers of children with citrin deficiency: a qualitative study.基于家庭的饮食管理对 citrin 缺乏症患儿照顾者的障碍:一项定性研究。
Orphanet J Rare Dis. 2022 Jul 8;17(1):256. doi: 10.1186/s13023-022-02437-z.
目前针对尼曼匹克 C 型疾病(NICCD)和适应/代偿期 citrin 缺乏症的治疗:预防 CTLN2 的策略。
Mol Genet Metab. 2019 Jul;127(3):175-183. doi: 10.1016/j.ymgme.2019.06.004. Epub 2019 Jun 15.
4
Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.基于小鼠模型的研究表明,器官间天冬氨酸代谢在治疗线粒体天冬氨酸-谷氨酸载体 2(citrin)缺陷中的关键作用。
Sci Rep. 2019 Mar 12;9(1):4179. doi: 10.1038/s41598-019-39627-y.
5
Growth impairment in individuals with citrin deficiency.患有 citrin 缺乏症个体的生长障碍。
J Inherit Metab Dis. 2019 May;42(3):501-508. doi: 10.1002/jimd.12051. Epub 2019 Feb 4.
6
Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.中链甘油三酯补充疗法与低碳水化合物配方联合应用,可以为成年发病型 II 型瓜氨酸血症患者的肝细胞提供能量并增强氨解毒。
J Inherit Metab Dis. 2018 Sep;41(5):777-784. doi: 10.1007/s10545-018-0176-1. Epub 2018 Apr 12.
7
Effectiveness of Medium-Chain Triglyceride Oil Therapy in Two Japanese Citrin-Deficient Siblings: Evaluation Using Oral Glucose Tolerance Tests.中链甘油三酯油疗法对两名日本柑橘素缺乏症同胞的疗效:通过口服葡萄糖耐量试验进行评估
Tohoku J Exp Med. 2016 Dec;240(4):323-328. doi: 10.1620/tjem.240.323.
8
Fatigue and quality of life in citrin deficiency during adaptation and compensation stage.瓜氨酸血症Ⅰ型适应期和代偿期的疲劳和生活质量。
Mol Genet Metab. 2013 May;109(1):9-13. doi: 10.1016/j.ymgme.2013.01.020. Epub 2013 Feb 9.
9
Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency.采用低乳糖(半乳糖)并补充中链甘油三酯的配方奶治疗因瓜氨酸缺乏引起的新生儿肝内胆汁淤积症。
JIMD Rep. 2012;2:37-44. doi: 10.1007/8904_2011_42. Epub 2011 Sep 6.
10
Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative data.141 个发展中国家轻度、中度和重度发育迟缓以及消瘦的趋势以及实现千年发展目标 1 的进展情况:基于人群代表性数据的系统分析。
Lancet. 2012 Sep 1;380(9844):824-34. doi: 10.1016/S0140-6736(12)60647-3. Epub 2012 Jul 5.